Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by Ryeman40 on Dec 10, 2020 4:46pm

Long term

This is one of my long term holds. I have a lot of shares and more than likely will buy more if i can. My timeline is around a year. 

There has been a few research papers from the Japanese, Korean and Chinese on the incredible benefits of H2S but they all have said more research needs to be done. Enter Antibe. 

With the adaptive phase 3 design i believe we should know after 50% of patients have completed treatment if we have an absolute winner. If Antibe doesn't need to increase sample size i think there will be a lot of attention turning Antibes way for a potential blockbuster and there's already been a few in the nsaid market. Pros for adaptive design are reduced potential cost, higher potential success  and stakeholder buy-in. 

IMHO i believe something like this comes along once in awhile and I've missed out on a few but not this time.

Comment by Forestview on Dec 10, 2020 5:06pm
Well said Ryeman.  I'm long term as well.  Sometimes frustrated with the lack of news and stagnant SP, but I'm not selling.  
Comment by Ryeman40 on Dec 11, 2020 1:29pm
All the good points i got from interview  13:30 Dan says if you solve problem with nsaid safety the drug is worth 30billion lifetime 20:00 Dr. Stauffer was actually involved in developing opioids  21:15 Their "unknown university" has one of the best chemists in H2S and working on different indications and fresh ip's 32:40 After foray into US institutional investors ...more  
Comment by Actuarial on Dec 11, 2020 1:38pm
Great summary! If ATE be able to deal with Alz, then this inidcation itself is worth at least $10Billion. Just look at Biogen market cap before and after FDA advisory committee meeting on aducanumab. GLTA!
Comment by MrMugsy on Dec 11, 2020 1:42pm
Exactly Actuarial.  We will build an industry ... if gaseous mediators and our lead are truely real.  If we can get the academic studies to prove out and attain a new lead on the world ... money in the bank !!!! Key here is ... IF I choose to believe !!!!
Comment by MrMugsy on Dec 11, 2020 1:40pm
Right-o Ryman. I think the price will appreciate though. Just finished a long thought on CEO but will say this here ... I expect that JP Morgan will bring some excitement after January 11-14 and we should see the comprehensive corporate update a day or two earlier than that - guessing.  Hoping that gets all these new investors and institutional buyers ramping up their purchases and our ...more  
Comment by Ryeman40 on Dec 11, 2020 1:53pm
  I really do hope that there is a lot of excitement after meetings and we get a lot of buying and we uplist asap but i won't be selling any time soon. I have 63 730 shares after reverse split and i know this stock can have the potential to move big given right circumstances.  I've made 28k off of BNS and ELD this year but literally lost out on another 53k by selling and not ...more  
Comment by MrMugsy on Dec 11, 2020 2:25pm
Agreed. Similar kinda boat as you w.r.t. ATE. Holding shares for dear life - no one's taking these from me - not even from my cold - dead -hands.  Hahaha !
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities